Valuation BioHarvest Sciences Inc. Canadian Securities Exchange
Stocks
BHSC
CA13767B1013
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3500 CAD | +6.06% |
|
-2.94% | +46.67% |
Company Valuation: BioHarvest Sciences Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 75.75 | 107.1 | 117.6 | 76.62 | - | - |
| Change | - | 41.36% | 9.8% | -34.84% | - | - |
| Enterprise Value (EV) | 75.75 | 107.1 | 117.6 | 76.62 | 76.62 | 76.62 |
| Change | - | 41.36% | 9.8% | -34.84% | 0% | 0% |
| P/E Ratio | -5.28x | -7.73x | -8.65x | -8.29x | -20.5x | 8.35x |
| PBR | - | - | - | - | - | - |
| PEG | - | 0.3x | 0.3x | 0.3x | 0.3x | -0x |
| Capitalization / Revenue | - | 4.25x | 3.41x | 1.79x | 1.3x | 0.88x |
| EV / Revenue | - | 0x | 0x | 1.79x | 1.3x | 0.88x |
| EV / EBITDA | - | -0x | -0x | -14.9x | 258x | 5.71x |
| EV / EBIT | - | -0x | -0x | -11.6x | -46.8x | 7.66x |
| EV / FCF | - | -0x | -0x | -5.31x | -16.5x | 11x |
| FCF Yield | - | -8.89% | -8.15% | -18.8% | -6.04% | 9.09% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.05 | -0.8 | -0.6 | -0.4075 | -0.165 | 0.405 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 25.19 | 34.51 | 42.89 | 58.96 | 86.86 |
| EBITDA 1 | - | -5.738 | -3.951 | -5.134 | 0.2975 | 13.42 |
| EBIT 1 | - | -6.989 | -5.575 | -6.588 | -1.638 | 9.997 |
| Net income 1 | -12.56 | -12.91 | -11.14 | -9.266 | -3.773 | 10.31 |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 5.539 | 6.180 | 5.190 | 3.380 | 3.380 | 3.380 |
| Nbr of stocks (in thousands) | 13,677 | 17,328 | 22,654 | 22,668 | - | - |
| Announcement Date | 4/30/24 | 3/31/25 | 3/31/26 | - | - | - |
1USD in Million2USD
Estimates
P/E Ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 15.95x | 1.9x | 12.22x | 5.38% | 13.22B | |
| 24.52x | 1.55x | 10.03x | 2.27% | 5.03B | |
| 16.13x | 3.2x | 9.81x | 5.49% | 4.66B | |
| 17.46x | - | - | 1.34% | 3.93B | |
| 26.23x | - | - | - | 3.89B | |
| 16.2x | 2.14x | 9.43x | 2.79% | 3.21B | |
| 13.98x | 2.76x | 11.74x | 5.76% | 1.75B | |
| Average | 18.64x | 2.31x | 10.64x | 3.84% | 5.1B | |
| Weighted average by Cap. | 18.39x | 2.14x | 11.07x | 4.16% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BHST Stock
- BHSC Stock
- Valuation BioHarvest Sciences Inc.
Select your edition
All financial news and data tailored to specific country editions
